Table 3 Univariable logistic regression analyses for discontinuation of PCA after general surgery.

From: Risk factors for discontinuation of intravenous patient-controlled analgesia after general surgery: a retrospective cohort study

Variable

OR (95% CI)

P-value

Age, year

1.00 (0.99, 1.00)

0.589

Female sex (vs male sex)

2.72 (2.27, 3.26)

 < 0.001

LOS after surgery, day

0.95 (0.93, 0.98)

 < 0.001

Medical history

 DM

0.92 (0.68, 1.24)

0.581

 HTN

0.92 (0.72, 1.16)

0.462

 CKD

0.72 (0.39, 1.32)

0.285

 Heart disease

1.19 (0.76, 1.85)

0.448

 Brain disease

1.39 (0.89, 2.17)

0.148

 Liver disease

  

Anesthesia

 General anesthesia

1

 

 Spinal anesthesia

0.00 (0.00)

0.998

ASA physical status classification

0.935

 1

1

 

 2

1.00 (0.80, 1.25)

0.998

 ≥ 3

1.04 (0.79, 1.37)

0.786

Laparoscopy (vs laparotomy)

1.21 (1.01, 1.44)

0.043

Type of surgery

0.018

 Stomach

1

 

 Colon

0.88 (0.69, 1.13)

0.321

 Hepato-pancreatic-biliary

1.29 (0.99, 1.68)

0.063

 Breast

0.73 (0.53, 1.02)

0.069

 Small bowel

1.35 (0.90, 2.02)

0.149

 Transplantation

0.94 (0.49, 1.84)

0.864

 Vascular

0.70 (0.22, 2.25)

0.545

 Others

1.11 (0.86, 1.43)

0.427

PCA type

 Opioid included

1

 

 NSAID only

0.63 (0.40, 1.00)

0.048

Background infusion (vs no background infusion)

1.38 (1.02, 1.85)

0.035

Preoperative drug usage

 NSAID

0.90 (0.61, 1.33)

0.600

 Paracetamol

0.72 (0.49, 1.04)

0.082

 Opioid

0.56 (0.37, 0.83)

0.004

  1. LOS length of hospital stays, DM diabetes mellitus, HTN hypertension, CKD chronic kidney disease, ASA American Society of Anesthesiologists, PCA patient-controlled analgesia, NSAID non-steroidal anti-inflammatory drug.